119-hr3749

HR
✓ Complete Data

HER Act

Login to track bills
Introduced:
Jun 5, 2025
Policy Area:
Health

Bill Statistics

3
Actions
3
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jun 5, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Jun 5, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Jun 5, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Jun 5, 2025

Subjects (1)

Health (Policy Area)

Cosponsors (3)

Text Versions (1)

Introduced in House

Jun 5, 2025

Full Bill Text

Length: 4,639 characters Version: Introduced in House Version Date: Jun 5, 2025 Last Updated: Nov 13, 2025 6:39 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3749 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 3749

To direct the Secretary of Health and Human Services to award grants
for research, investigation, and awareness of the effect of personal
care products containing endocrine-disrupting chemicals on the female
reproductive system, and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

June 5, 2025

Ms. Brown (for herself, Mrs. McIver, Mr. Johnson of Georgia, and Ms.
Pressley) introduced the following bill; which was referred to the
Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To direct the Secretary of Health and Human Services to award grants
for research, investigation, and awareness of the effect of personal
care products containing endocrine-disrupting chemicals on the female
reproductive system, and for other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Health and Endocrine Research on
personal care products for women Act'' or the ``HER Act''.
SEC. 2.
ENDOCRINE-DISRUPTING CHEMICALS IN PERSONAL CARE PRODUCTS.

(a) Research Grants.--

(1) In general.--The Secretary of Health and Human
Services, acting through the Director of the National Institute
of Environmental Health Sciences, shall award grants for
research on the impact of personal care products containing
endocrine-disrupting chemicals on the female reproductive
system and related reproductive toxicity concerns.

(2) Reports.--Not later than 5 years after the date of
enactment of this Act, and every 5 years thereafter, the
Secretary shall submit to the Congress, and make publicly
available on the appropriate website of the Department of
Health and Human Services, a report based on the results of the
research under paragraph

(1) . Such report shall--
(A) outline research developments and findings
related to disparities in access to safe non-endocrine-
disrupting personal care products;
(B) list safe and harmful personal care products,
as determined by the Secretary; and
(C) include evidence-based or evidence-informed
legislative or administrative strategies to increase
the Food and Drug Administration's domain to regulate
personal care product ingredients that are endocrine-
disrupting chemicals that harm women's reproductive
health.

(b) State Grants for Investigation and Awareness.--

(1) In general.--The Secretary shall award grants to States
for carrying out--
(A) programs to investigate the impact of personal
care products containing endocrine-disrupting chemicals
on women's reproductive health; and
(B) programs to develop and implement public
awareness and education campaigns about the use of
alternative personal care products that are less
harmful to human health.

(2) Reports.--Not later than 5 years after the initial
awarding of grants under paragraph

(1) , and every 5 years
thereafter, the Secretary shall submit to the Congress, and
make publicly available on the appropriate website of the
Department of Health and Human Services, a report summarizing
the findings and results of the programs and activities funded
through the grants under paragraph

(1) .
(c) === Definitions. ===
-In this section:

(1) Endocrine-disrupting chemical.--The term ``endocrine-
disrupting chemical'' means a chemical that mimics, blocks, or
interferes with the body's hormones.

(2) Personal care product.--The term ``personal care
product'' means a product that--
(A) is a cosmetic (as defined in
section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321));
and
(B) is intended to support the hygiene, grooming,
or other personal care of the human body.

(3) Secretary.--The term ``Secretary'' means the Secretary
of Health and Human Services.

(4) State.--The term ``State'' means--
(A) each of the several States, the District of
Columbia, and the territories of the United States; and
(B) an Indian Tribe or Tribal organization (as such
terms are defined in
section 4 of the Indian Self- Determination and Education Assistance Act (25 U.
Determination and Education Assistance Act (25 U.S.C.
5304)).
<all>